Friday, 24 June 2011

Rexahn Pharmaceuticals Completes Patient Enrollment In Serdaxin Phase IIb Clinical Trial For Major Depressive Disorder

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)